
Person of The Week
Team of The Year | Red Border by TIME
Dec 5, 2023
Pfizer's women leaders in vaccine science breaking barriers, HP's social impact team accelerating digital equity for 150 million people, and how Syngenta's R&D team drives innovation in agriculture.
21:29
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Pfizer's women leaders broke barriers in vaccine science, achieving a major breakthrough in RSV vaccine development for vulnerable populations.
- HP's social impact team is accelerating digital equity by providing education, healthcare, and economic opportunities to underserved communities worldwide through technology access and digital literacy.
Deep dives
Pfizer's Groundbreaking Achievement in RSV Vaccine Development
In 2023, Pfizer's Vaccines team achieved a major scientific breakthrough in RSV vaccine development. The vaccine was approved by the FDA for individuals aged 60 and older, as well as pregnant people at 32 through 36 weeks. This milestone was significant for public health due to RSV's impact on vulnerable populations, particularly children under five in low and middle income countries. Pfizer's team, driven by personal stories, overcame decades of research obstacles to develop this vaccine, highlighting the importance of teamwork in scientific advancements.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.